Medical Countermeasures Why Moderna Won’t Share Rights to the COVID-19 Vaccine with the Government That Paid for Its Development by Ana Santos Rutschman November 18, 2021
Industry News Birmingham Biotech and University of Birmingham Partner on Covid-19 Anti-viral Nasal Spray by Ana Santos Rutschman November 9, 2021
Medical Countermeasures Nose Sprays, Needle-Free Patches, Durable Immunity: Towards the Next Generation of COVID Vaccines by Ana Santos Rutschman November 8, 2021
Medical Countermeasures Vaccination Offers Higher Protection Than Previous COVID-19 Infection by Ana Santos Rutschman October 29, 2021
Industry News Rwanda and Senegal Will Host Africa’s First COVID-19 Vaccine Manufacturing Plants by Ana Santos Rutschman October 27, 2021
Medical Countermeasures Ivermectin: Misuse Against COVID Risks Undermining Its Use for Other Diseases by Ana Santos Rutschman October 27, 2021
Medical Countermeasures Navigating New Federal Rules on ‘Mix-and-Match’ Vaccine Booster Shots by Ana Santos Rutschman October 27, 2021
Medical Countermeasures Data Shows Continued Vulnerability of Vaccinated Blood Cancer Patients to COVID-19 by Ana Santos Rutschman October 23, 2021
Medical Countermeasures How a BBQ Lighter Sparked a Breakthrough Idea on Vaccine Delivery by Ana Santos Rutschman October 23, 2021
Funding News Sabin Vaccine Institute Receives Additional $34.5M from BARDA for Further Development of Ebola Sudan and Marburg Vaccines by Ana Santos Rutschman October 21, 2021
Medical Countermeasures Moderna COVID Booster Study in Rhesus Macaques Shows Increased Antibody Response by Ana Santos Rutschman October 21, 2021
CBRNE “Resurrector” Drugs Have Potential to Rescue Aged AChE to Fight Nerve Agents by Ana Santos Rutschman October 17, 2021
Medical Countermeasures New Antiviral Compound Blocks SARS-CoV-2 From Entering Cells by Ana Santos Rutschman October 13, 2021
Antimicrobial Resistance MIT Researchers Make Progress on Antibiotic Resistance Under DTRA-JSTO Research Program by Ana Santos Rutschman October 12, 2021
CBRNE First-in-Class Nerve Agent Antidote Crosses Blood-Brain Barrier to Aid Central Nervous System by Ana Santos Rutschman October 12, 2021
CBRNE Understanding How the Microbiome Affects Radiation Injury for Countermeasure Development by Ana Santos Rutschman October 11, 2021
Medical Countermeasures Dynavax and DoD Announce Collaboration to Develop an Adjuvanted Plague Vaccine by Ana Santos Rutschman October 4, 2021
Industry News Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA by Ana Santos Rutschman October 3, 2021
